Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
borneol (1 trial)
capecitabine (xeloda) (1 trial)
docetaxel (taxotere) (1 trial)
paclitaxel (taxol) (1 trial)
rc48-adc (1 trial)
vinorelbine (navelbine) (1 trial)
Breast Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (6 total)